[go: up one dir, main page]

ZA200908262B - Macrocycles and their uses - Google Patents

Macrocycles and their uses

Info

Publication number
ZA200908262B
ZA200908262B ZA200908262A ZA200908262A ZA200908262B ZA 200908262 B ZA200908262 B ZA 200908262B ZA 200908262 A ZA200908262 A ZA 200908262A ZA 200908262 A ZA200908262 A ZA 200908262A ZA 200908262 B ZA200908262 B ZA 200908262B
Authority
ZA
South Africa
Prior art keywords
macrocycles
Prior art date
Application number
ZA200908262A
Other languages
English (en)
Inventor
Roger Aki Fujimoto
Philipp Krastel
Matthew J Lamarche
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ZA200908262B publication Critical patent/ZA200908262B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA200908262A 2007-06-04 2009-11-23 Macrocycles and their uses ZA200908262B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US94177707P 2007-06-04 2007-06-04

Publications (1)

Publication Number Publication Date
ZA200908262B true ZA200908262B (en) 2010-08-25

Family

ID=40094226

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200908262A ZA200908262B (en) 2007-06-04 2009-11-23 Macrocycles and their uses

Country Status (24)

Country Link
US (2) US8476224B2 (xx)
EP (1) EP2170907A2 (xx)
JP (1) JP2010529076A (xx)
KR (1) KR101202483B1 (xx)
CN (1) CN101772506B (xx)
AR (1) AR066865A1 (xx)
AU (1) AU2008258639B2 (xx)
BR (1) BRPI0812340A2 (xx)
CA (1) CA2688621A1 (xx)
CL (1) CL2008001613A1 (xx)
CO (1) CO6270222A2 (xx)
CR (1) CR11158A (xx)
EA (1) EA200901613A1 (xx)
EC (1) ECSP099836A (xx)
GT (1) GT200900310A (xx)
IL (1) IL202285A0 (xx)
MA (1) MA31562B1 (xx)
MX (1) MX2009013214A (xx)
NZ (1) NZ581917A (xx)
PE (1) PE20090318A1 (xx)
TN (1) TN2009000495A1 (xx)
TW (1) TW200902540A (xx)
WO (1) WO2008148754A2 (xx)
ZA (1) ZA200908262B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2708793C (en) 2007-12-12 2016-06-21 Novartis Ag Aminothiazoles and their uses
WO2018073269A1 (en) * 2016-10-21 2018-04-26 Xellia Pharmaceuticals Aps Liquid formulations of daptomycin
CN109485617B (zh) * 2018-12-11 2023-01-31 贵州永诺菲特生物制药有限公司 一种n-甲基-2-异丙基-4-噻唑甲胺的制备方法
WO2024044751A2 (en) * 2022-08-26 2024-02-29 Wake Forest University Health Sciences Peroxiredoxin 3 inhibitors and methods of use for treating cancer
WO2025038747A1 (en) * 2023-08-14 2025-02-20 Rs Oncology, Llc Modified thiostrepton-inspired compounds for treatment of cancer and preparation thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2071143T3 (es) * 1990-03-08 1995-06-16 Lepetit Spa Factores b1, b2, c1, c2, d1, d2, e y t del antibiotico ge 2270.
DE9004073U1 (de) 1990-04-07 1990-06-13 Auto-Kabel Hausen GmbH & Co. Betriebs-KG, 79688 Hausen Anschlußklemme für Akkumulator o.dgl.
IL100572A (en) * 1991-01-03 1997-01-10 Lepetit Spa Amides of antibiotic ge 2270 factors their preparation and pharmaceutical compositions containing them
ATE163428T1 (de) * 1991-08-30 1998-03-15 Biosearch Italia Spa Faktor c2a des antibiotikums ce 2270
US6008225A (en) * 1996-02-14 1999-12-28 Biosearch Italia, S.P.A. Derivatives of antibiotic GE2270 factors C2a, D2 and E
JPH1059997A (ja) * 1996-08-22 1998-03-03 Microbial Chem Res Found アミチアマイシンアミド誘導体
EP1553967B1 (en) * 2002-06-17 2011-05-18 NAICONS s.c.a.r.l. Use of amide derivative of ge 2270 factor a3 for the treatment of acne
US20050106159A1 (en) * 2003-08-12 2005-05-19 Thompson Stuart A. Campylobacter jejuni outer membrane protein immunogenic composition
AR060977A1 (es) * 2006-05-31 2008-07-23 Novartis Ag Aminotiazoles y sus usos
EP2097423B1 (en) * 2006-12-20 2011-03-02 Novartis AG Aminothiazole macrocycles, their use as antibacterial compounds and processes for their production

Also Published As

Publication number Publication date
US20090186830A1 (en) 2009-07-23
ECSP099836A (es) 2010-01-29
GT200900310A (es) 2010-05-21
CO6270222A2 (es) 2011-04-20
TN2009000495A1 (en) 2011-03-31
CA2688621A1 (en) 2008-12-11
US8691756B2 (en) 2014-04-08
CR11158A (es) 2010-01-20
IL202285A0 (en) 2010-06-16
AR066865A1 (es) 2009-09-16
TW200902540A (en) 2009-01-16
JP2010529076A (ja) 2010-08-26
MA31562B1 (fr) 2010-08-02
CN101772506A (zh) 2010-07-07
AU2008258639A1 (en) 2008-12-11
KR101202483B1 (ko) 2012-11-16
NZ581917A (en) 2011-04-29
WO2008148754A2 (en) 2008-12-11
WO2008148754A3 (en) 2009-03-05
AU2008258639B2 (en) 2012-07-05
US20130252883A1 (en) 2013-09-26
KR20100021496A (ko) 2010-02-24
US8476224B2 (en) 2013-07-02
BRPI0812340A2 (pt) 2015-01-27
EA200901613A1 (ru) 2010-06-30
CL2008001613A1 (es) 2009-05-15
CN101772506B (zh) 2014-02-12
PE20090318A1 (es) 2009-04-17
EP2170907A2 (en) 2010-04-07
MX2009013214A (es) 2010-01-15

Similar Documents

Publication Publication Date Title
IL205571A0 (en) 4-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin
TWI561237B (en) Substituted dihydropyrazolones and their use
GB0701426D0 (en) Compounds and their use
EP2185692A4 (en) HCO32 AND HCO27 AND RELATED EXAMPLES
PT2114900T (pt) Compostos à base de tiopirimidina e as suas utilizações
PL2034088T3 (pl) Tkanina i laminat tkaniny
IL210804A (en) Benzylidenehydrazides and their uses
ZA200810323B (en) Fkbp-l and uses thereof
SI2137186T1 (sl) Heterociklične spojine in njihove uporabe
SI2064327T1 (sl) DBAIT in njegova uporaba
PL2222314T3 (pl) Zastosowanie i sposoby uzyskania rozluźnienia oskrzeli
EP2291377A4 (en) IMIDAZOPYRIMIDINONE AND ITS USES
ZA200903906B (en) Carboranylporphyrins and uses thereof
ZA201103456B (en) Leukolectins and uses thereof
GB2452568B (en) Fabric and fabric laminate
PL2247601T3 (pl) Tiazopirymidynony i ich zastosowanie
ZA200908262B (en) Macrocycles and their uses
ZA201000357B (en) 2-Azetidinemethaneamines and 2-pyrrolidinemethaneamines as Taar-Ligands
IL206104A0 (en) Aminothiazoles and their uses
ZA201100182B (en) New terpenes and macrocycles
GB0707069D0 (en) Methods and uses
GB0708445D0 (en) Compounds and uses thereof
HK1141286A (en) Macrocycles and their uses
GB0707609D0 (en) Methods and uses
GB0722451D0 (en) Methods and uses